_id
6915fd22bc934aba376b27df
Ticker
SPDE
Name
Speedus Corp
Exchange
OTCCE
Address
1 Dag Hammarskjold Boulevard, Freehold, NJ, United States, 07728
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.speedus.com
Description
Speedus Corp., through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States. The company offers computer-aided medical devices and telemedicine based delivery systems, including Zargis Cardioscan device, a non-invasive diagnostic support solution that automatically analyzes acoustical data from a patient to determine whether or not the patient possesses a suspected diastolic or systolic murmur; ZargisTelemed portal; and Signal X6 device, which records heart and lung sounds from six adhesive acoustic sensors. It also develops and markets ultra-high speed storage systems comprising JetX10 acceleration appliance, JetPod, and JetNode expansion chassis for server networks and other applications. In addition, the company offers local multipoint distribution service license, an FCC commercial operating license, which covers between 150"300 MHz of spectrum in the New York City area. Further, it holds investments in a portfolio of marketable securities and in equity and debt instruments of non-publicly held companies. The company was formerly known as SPEEDUS.COM, Inc. and changed its name to Speedus Corp. in May 2002. Speedus Corp. was founded in 1995 and is based in Freehold, New Jersey.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-07T12:13:01.250Z
Image
-
Ipo Date
1996-02-08T00:00:00.000Z
Market Cap
416
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2010-09-30
Revenue
173838
Cost Of Revenue
62906
Gross Profit
110932
Operating Expenses
1022586
Operating Income
-848748
Interest Expense
29534
Pretax Income
-838258
Net Income
-746084
Eps
-
Dividends Per Share
0
Shares Outstanding
4162326
Income Tax Expense
0
EBITDA
-
Operating Margin
-488.2407758947986
Total Other Income Expense Net
10490
Cash
106278
Short Term Investments
2484
Receivables
55032
Inventories
99515
Total Current Assets
332234
Property Plant Equipment
31122
Total Assets
385803
Payables
664245
Short Term Debt
0
Long Term Debt
404700
Total Liabilities
2638735
Equity
-1317906
Bs_currency_symbol
USD
Depreciation
6151
Change In Working Capital
-
Cash From Operations
-492435
Capital Expenditures
7975
Cash From Investing
-7975
Cash From Financing
206630
Net Change In Cash
-293780
Cf_currency_symbol
USD
PE
-
PB
0
ROE
56.6113212930209
ROA
-193.38470670264357
FCF
-500410
Fcf Percent
-2.8785996157341893
Piotroski FScore
1
Health Score
37
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2010-09-30
Quarters > 0 > income Statement > revenue
173838
Quarters > 0 > income Statement > cost Of Revenue
62906
Quarters > 0 > income Statement > gross Profit
110932
Quarters > 0 > income Statement > operating Expenses
1022586
Quarters > 0 > income Statement > operating Income
-848748
Quarters > 0 > income Statement > interest Expense
29534
Quarters > 0 > income Statement > pretax Income
-838258
Quarters > 0 > income Statement > net Income
-746084
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
0
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-488.2407758947986
Quarters > 0 > income Statement > total Other Income Expense Net
10490
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
106278
Quarters > 0 > balance Sheet > short Term Investments
2484
Quarters > 0 > balance Sheet > receivables
55032
Quarters > 0 > balance Sheet > inventories
99515
Quarters > 0 > balance Sheet > total Current Assets
332234
Quarters > 0 > balance Sheet > property Plant Equipment
31122
Quarters > 0 > balance Sheet > total Assets
385803
Quarters > 0 > balance Sheet > payables
664245
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
404700
Quarters > 0 > balance Sheet > total Liabilities
2638735
Quarters > 0 > balance Sheet > equity
-1317906
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-746084
Quarters > 0 > cash Flow > depreciation
6151
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-492435
Quarters > 0 > cash Flow > capital Expenditures
7975
Quarters > 0 > cash Flow > cash From Investing
-7975
Quarters > 0 > cash Flow > cash From Financing
206630
Quarters > 0 > cash Flow > net Change In Cash
-293780
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0
Quarters > 0 > ratios > ROE
56.6113212930209
Quarters > 0 > ratios > ROA
-193.38470670264357
Quarters > 0 > ratios > FCF
-500410
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-2.8785996157341893
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2010-06-30
Quarters > 1 > income Statement > revenue
99946
Quarters > 1 > income Statement > cost Of Revenue
35717
Quarters > 1 > income Statement > gross Profit
64229
Quarters > 1 > income Statement > operating Expenses
1654960
Quarters > 1 > income Statement > operating Income
-1555014
Quarters > 1 > income Statement > interest Expense
24299
Quarters > 1 > income Statement > pretax Income
-1539251
Quarters > 1 > income Statement > net Income
-1414339
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
0
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-1555.8541612470733
Quarters > 1 > income Statement > total Other Income Expense Net
15763
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
400058
Quarters > 1 > balance Sheet > short Term Investments
3771
Quarters > 1 > balance Sheet > receivables
51086
Quarters > 1 > balance Sheet > inventories
127868
Quarters > 1 > balance Sheet > total Current Assets
621543
Quarters > 1 > balance Sheet > property Plant Equipment
29298
Quarters > 1 > balance Sheet > total Assets
673288
Quarters > 1 > balance Sheet > payables
475752
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
404700
Quarters > 1 > balance Sheet > total Liabilities
2143021
Quarters > 1 > balance Sheet > equity
-626881
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1414339
Quarters > 1 > cash Flow > depreciation
5643
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-886337
Quarters > 1 > cash Flow > capital Expenditures
3900
Quarters > 1 > cash Flow > cash From Investing
-3900
Quarters > 1 > cash Flow > cash From Financing
204529
Quarters > 1 > cash Flow > net Change In Cash
-685708
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
0
Quarters > 1 > ratios > ROE
225.61522840858154
Quarters > 1 > ratios > ROA
-210.06448949038153
Quarters > 1 > ratios > FCF
-890237
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-8.907179877133652
Quarters > 1 > health Score
37
Quarters > 2 > quarter
2010-03-31
Quarters > 2 > income Statement > revenue
137967
Quarters > 2 > income Statement > cost Of Revenue
12747
Quarters > 2 > income Statement > gross Profit
125220
Quarters > 2 > income Statement > operating Expenses
1130833
Quarters > 2 > income Statement > operating Income
-992866
Quarters > 2 > income Statement > interest Expense
24188
Quarters > 2 > income Statement > pretax Income
-1018157
Quarters > 2 > income Statement > net Income
-895613
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
0
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-719.6402038168548
Quarters > 2 > income Statement > total Other Income Expense Net
-25291
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1085766
Quarters > 2 > balance Sheet > short Term Investments
3692
Quarters > 2 > balance Sheet > receivables
67968
Quarters > 2 > balance Sheet > inventories
119966
Quarters > 2 > balance Sheet > total Current Assets
1292906
Quarters > 2 > balance Sheet > property Plant Equipment
31041
Quarters > 2 > balance Sheet > total Assets
1346394
Quarters > 2 > balance Sheet > payables
460225
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
1380768
Quarters > 2 > balance Sheet > total Liabilities
2058680
Quarters > 2 > balance Sheet > equity
6054
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-895613
Quarters > 2 > cash Flow > depreciation
5754
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-863100
Quarters > 2 > cash Flow > capital Expenditures
3900
Quarters > 2 > cash Flow > cash From Investing
1750000
Quarters > 2 > cash Flow > cash From Financing
48856
Quarters > 2 > cash Flow > net Change In Cash
935756
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
0
Quarters > 2 > ratios > ROE
-14793.739676247109
Quarters > 2 > ratios > ROA
-66.51938437039975
Quarters > 2 > ratios > FCF
-867000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-6.28411141794777
Quarters > 2 > health Score
14
Quarters > 3 > quarter
2009-12-31
Quarters > 3 > income Statement > revenue
139241
Quarters > 3 > income Statement > cost Of Revenue
22345
Quarters > 3 > income Statement > gross Profit
116896
Quarters > 3 > income Statement > operating Expenses
2403501
Quarters > 3 > income Statement > operating Income
-2264260
Quarters > 3 > income Statement > interest Expense
24410
Quarters > 3 > income Statement > pretax Income
-1086000
Quarters > 3 > income Statement > net Income
253865
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
0
Quarters > 3 > income Statement > income Tax Expense
-1183184
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-1626.1445982146065
Quarters > 3 > income Statement > total Other Income Expense Net
1178260
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
150010
Quarters > 3 > balance Sheet > short Term Investments
1754960
Quarters > 3 > balance Sheet > receivables
54975
Quarters > 3 > balance Sheet > inventories
98222
Quarters > 3 > balance Sheet > total Current Assets
2066167
Quarters > 3 > balance Sheet > property Plant Equipment
36795
Quarters > 3 > balance Sheet > total Assets
2125409
Quarters > 3 > balance Sheet > payables
350386
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
1356580
Quarters > 3 > balance Sheet > total Liabilities
1933358
Quarters > 3 > balance Sheet > equity
787847
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
253865
Quarters > 3 > cash Flow > depreciation
6645
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-1015544
Quarters > 3 > cash Flow > capital Expenditures
14308
Quarters > 3 > cash Flow > cash From Investing
-14326
Quarters > 3 > cash Flow > cash From Financing
131400
Quarters > 3 > cash Flow > net Change In Cash
-898470
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
0
Quarters > 3 > ratios > ROE
32.22262698214247
Quarters > 3 > ratios > ROA
11.944289310904395
Quarters > 3 > ratios > FCF
-1029852
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-7.396183595349071
Quarters > 3 > health Score
44
Annuals > 0 > quarter
2009-12-31
Annuals > 0 > income Statement > revenue
461177
Annuals > 0 > income Statement > cost Of Revenue
166327
Annuals > 0 > income Statement > gross Profit
294850
Annuals > 0 > income Statement > operating Expenses
6364754
Annuals > 0 > income Statement > operating Income
-5903577
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-4622775
Annuals > 0 > income Statement > net Income
-2843795
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
0
Annuals > 0 > income Statement > income Tax Expense
-1183184
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-1280.110890178825
Annuals > 0 > income Statement > total Other Income Expense Net
1280802
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
150010
Annuals > 0 > balance Sheet > short Term Investments
1754960
Annuals > 0 > balance Sheet > receivables
54975
Annuals > 0 > balance Sheet > inventories
98222
Annuals > 0 > balance Sheet > total Current Assets
2066167
Annuals > 0 > balance Sheet > property Plant Equipment
36795
Annuals > 0 > balance Sheet > total Assets
2125409
Annuals > 0 > balance Sheet > payables
350386
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
1356580
Annuals > 0 > balance Sheet > total Liabilities
1933358
Annuals > 0 > balance Sheet > equity
787847
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-2843795
Annuals > 0 > cash Flow > depreciation
24524
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-4399939
Annuals > 0 > cash Flow > capital Expenditures
14308
Annuals > 0 > cash Flow > cash From Investing
-1764308
Annuals > 0 > cash Flow > cash From Financing
306500
Annuals > 0 > cash Flow > net Change In Cash
-5857747
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
0
Annuals > 0 > ratios > ROE
-360.9577747963754
Annuals > 0 > ratios > ROA
-133.79989451442052
Annuals > 0 > ratios > FCF
-4414247
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-9.571698068203748
Annuals > 0 > health Score
12
Annuals > 1 > quarter
2008-12-31
Annuals > 1 > income Statement > revenue
155870
Annuals > 1 > income Statement > cost Of Revenue
30352
Annuals > 1 > income Statement > gross Profit
125518
Annuals > 1 > income Statement > operating Expenses
5471962
Annuals > 1 > income Statement > operating Income
-5316092
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-7444573
Annuals > 1 > income Statement > net Income
-9201876
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
0
Annuals > 1 > income Statement > income Tax Expense
1300000
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-3410.593443253994
Annuals > 1 > income Statement > total Other Income Expense Net
-2128481
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6007757
Annuals > 1 > balance Sheet > short Term Investments
2633
Annuals > 1 > balance Sheet > receivables
17390
Annuals > 1 > balance Sheet > inventories
30000
Annuals > 1 > balance Sheet > total Current Assets
6068458
Annuals > 1 > balance Sheet > property Plant Equipment
47011
Annuals > 1 > balance Sheet > total Assets
6137916
Annuals > 1 > balance Sheet > payables
174293
Annuals > 1 > balance Sheet > short Term Debt
0
Annuals > 1 > balance Sheet > long Term Debt
378110
Annuals > 1 > balance Sheet > total Liabilities
3157563
Annuals > 1 > balance Sheet > equity
2980353
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-9201876
Annuals > 1 > cash Flow > depreciation
97091
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-6069753
Annuals > 1 > cash Flow > capital Expenditures
13015
Annuals > 1 > cash Flow > cash From Investing
2983685
Annuals > 1 > cash Flow > cash From Financing
248467
Annuals > 1 > cash Flow > net Change In Cash
-2837601
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
0
Annuals > 1 > ratios > ROE
-308.75121168532723
Annuals > 1 > ratios > ROA
-149.9185717106588
Annuals > 1 > ratios > FCF
-6082768
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-39.02462308333868
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2007-12-31
Annuals > 2 > income Statement > revenue
11000
Annuals > 2 > income Statement > cost Of Revenue
17913
Annuals > 2 > income Statement > gross Profit
-6913
Annuals > 2 > income Statement > operating Expenses
4512334
Annuals > 2 > income Statement > operating Income
-4501334
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-3650333
Annuals > 2 > income Statement > net Income
-4418050
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
0
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-40921.218181818185
Annuals > 2 > income Statement > total Other Income Expense Net
851001
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
8859802
Annuals > 2 > balance Sheet > short Term Investments
3088890
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
10801843.45
Annuals > 2 > balance Sheet > total Current Assets
11967122
Annuals > 2 > balance Sheet > property Plant Equipment
21920
Annuals > 2 > balance Sheet > total Assets
13289567
Annuals > 2 > balance Sheet > payables
6629
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
1437216
Annuals > 2 > balance Sheet > equity
11852351
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-4418050
Annuals > 2 > cash Flow > depreciation
62527
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-3310380
Annuals > 2 > cash Flow > capital Expenditures
40261
Annuals > 2 > cash Flow > cash From Investing
1953289
Annuals > 2 > cash Flow > cash From Financing
-1718
Annuals > 2 > cash Flow > net Change In Cash
-1358809
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
0
Annuals > 2 > ratios > ROE
-37.275726984460725
Annuals > 2 > ratios > ROA
-33.244499237635054
Annuals > 2 > ratios > FCF
-3350641
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-304.60372727272727
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2006-12-31
Annuals > 3 > income Statement > revenue
846342
Annuals > 3 > income Statement > cost Of Revenue
306932
Annuals > 3 > income Statement > gross Profit
539410
Annuals > 3 > income Statement > operating Expenses
6662178
Annuals > 3 > income Statement > operating Income
-5815836
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-5615195
Annuals > 3 > income Statement > net Income
-5615195
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
0
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-687.1732703800591
Annuals > 3 > income Statement > total Other Income Expense Net
200641
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10204167
Annuals > 3 > balance Sheet > short Term Investments
5344261
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
15692082
Annuals > 3 > balance Sheet > property Plant Equipment
527828
Annuals > 3 > balance Sheet > total Assets
17135763
Annuals > 3 > balance Sheet > payables
62805
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
1033860
Annuals > 3 > balance Sheet > equity
16101903
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-5615195
Annuals > 3 > cash Flow > depreciation
757553
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-2899789
Annuals > 3 > cash Flow > capital Expenditures
270385
Annuals > 3 > cash Flow > cash From Investing
-5260635
Annuals > 3 > cash Flow > cash From Financing
-198497
Annuals > 3 > cash Flow > net Change In Cash
-8358921
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
0
Annuals > 3 > ratios > ROE
-34.872865648240456
Annuals > 3 > ratios > ROA
-32.76886474211857
Annuals > 3 > ratios > FCF
-3170174
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.745736357170033
Annuals > 3 > health Score
25
Valuation > metrics > PB
0
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
56.6113212930209
Profitability > metrics > ROA
-224.56581806798823
Profitability > metrics > Net Margin
-4.2918349267709015
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-28.737996884946163
Risk > final Score
-85
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.5001678597505439
Liquidity > metrics > Quick Ratio
0.3503511505543888
Liquidity > final Score
28
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
100
Prev Risks > 0
-226
Prev Risks > 1
-158
Prev Risks > 2
-353
Prev Liquidities > 0
83
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:36:39.192Z
Speedus Corp., through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States. The company offers computer-aided medical devices and telemedicine based delivery systems, including Zargis Cardioscan device, a non-invasive diagnostic support solution that automatically analyzes acoustical data from a patient to determine whether or not the patient possesses a suspected diastolic or systolic murmur; ZargisTelemed portal; and Signal X6 device, which records heart and lung sounds from six adhesive acoustic sensors. It also develops and markets ultra-high speed storage systems comprising JetX10 acceleration appliance, JetPod, and JetNode expansion chassis for server networks and other applications. In addition, the company offers local multipoint distribution service license, an FCC commercial operating license, which covers between 150"300 MHz of spectrum in the New York City area. Further, it holds investments in a portfolio of marketable securities and in equity and debt instruments of non-publicly held companies. The company was formerly known as SPEEDUS.COM, Inc. and changed its name to Speedus Corp. in May 2002. Speedus Corp. was founded in 1995 and is based in Freehold, New Jersey.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATHE GENERATION ESSENTIALS GROUP AND BLACK SPADE ACQUISITION II CO COMPLETE BUSINESS COMBINATION Yahoo Finance
Read more →Black Spade Announces Major Exchange Switch: Nasdaq Exit for NYSE Listing Following TGE Merger Stock Titan
Read more →Showing 2 of 8
(Last Updated 2010-09-30)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Speedus Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2010-09-30)
(Last Updated 2010-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2010-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2010-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.